جميع الدراسات
مُصرحالتأكيد العلاجي (المرحلة الثالثة)تداخلي

A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of a subcutaneous allergoid preparation of house dust mite allergens (Dermatophagoides pteronyssinus / Dermatophagoides farinae) in patients with moderate to severe allergic rhinitis/rhinoconjunctivitis with or without controlled allergic asthma.

House dust mites are tiny creatures living in household dust that can trigger constant sneezing, blocked noses, and itchy eyes. This clinical trial is testing an allergy injection treatment designed to help the immune system build tolerance to house dust mites. The study is looking for adults aged 18 and over who have moderate to severe dust mite allergies, with or without well-controlled asthma. Over about 12 months, participants will receive regular injections under the skin. Half will receive the active allergy treatment and half will receive a dummy injection (placebo). Doctors will track whether the injections ease day-to-day allergy symptoms and cut down the need for relief treatments, such as antihistamines and nasal sprays. Taking part helps researchers learn whether this therapy provides safe, long-term relief for people living with persistent dust mite allergies.

نظرة سريعة

الحالة
مُصرح
المرحلة
التأكيد العلاجي (المرحلة الثالثة)
الراعي
Allergopharma GmbH & Co. KG
الهدف من التسجيل
492
ابدأ
30 سبتمبر 2026

ما هو موضوع هذه الدراسة؟

House dust mites are microscopic bugs that thrive in warm indoor places like mattresses, bedding, and carpets. For many people, breathing in dust mite droppings triggers an allergic reaction, causing blocked or runny noses, sneezing fits, and red, itchy eyes. When these symptoms are moderate to severe, they can disrupt sleep, make working difficult, and reduce overall quality of life.

Most common allergy treatments, like standard antihistamines or nasal sprays, only ease symptoms temporarily. This study is testing an allergy immunotherapy, often called an 'allergy shot'. Instead of just hiding symptoms, this treatment introduces small, modified amounts of dust mite allergen under the skin to gently retrain the immune system so it stops overreacting.

This is a Phase 3 trial, which is the final testing stage before a medicine can be approved for general use. Researchers want to confirm how well the treatment works and check its safety compared to a dummy injection (placebo) over approximately 12 months. Finding better treatments could give people with dust mite allergies long-lasting relief without relying so heavily on daily medicines.

النقاط الرئيسية

  • Tests a new allergy injection designed to build long-term tolerance to house dust mites.
  • Open to adults aged 18 and older with moderate to severe dust mite allergies.
  • Lasts around 13 months and involves regular clinic visits for injections.
  • Half of the participants receive the active treatment and half receive a dummy injection (placebo).
  • Approved relief medicines are provided free to help control symptoms during the trial.

من قد يكون مؤهلاً؟

This study is open to adults aged 18 and older who have moderate to severe allergic rhinitis (inflammation inside the nose) and rhinoconjunctivitis (itchy, watery eyes) caused by house dust mites. Your symptoms should be troublesome enough to affect your daily life despite using standard allergy medicines.

People with asthma can take part, provided their asthma is allergic, mild to moderate, and currently well-controlled. If your asthma is severe, unstable, or prone to sudden flare-ups, you will not be able to join for safety reasons.

You may also be excluded if you have other serious health problems, are pregnant or breastfeeding, or have received similar allergy injections in the recent past. The study medical team will carry out detailed health checks to make sure taking part is completely safe for you.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. عمري 18 عامًا أو أكثر.
  2. I have been diagnosed with an allergy to house dust mites.
  3. My nose or eye allergy symptoms are moderate to severe.
  4. If I have asthma, it is well-controlled with my regular inhalers.
  5. I am willing to attend regular clinic appointments over roughly one year.
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

Taking part in this study lasts for around 13 months in total. You will visit a study clinic regularly to receive injections under your skin. Because this is a 'double-blind' trial, neither you nor your study doctor will know whether you are receiving the real allergy treatment or a harmless dummy injection (placebo).

During the trial, you will be asked to keep a daily diary of your allergy symptoms and any medications you take. The study team will provide free relief medicines—such as antihistamine tablets, eye drops, and a steroid nasal spray—to use if your allergy symptoms flare up. You will also have routine health checks, including simple blood tests and symptom questionnaires, to monitor your progress and safety.

المخاطر والفوائد المحتملة

You might experience an improvement in your allergy symptoms, and you will receive close medical monitoring throughout the trial. However, there is no guarantee of personal benefit, especially if you receive the placebo injection. Common risks include redness, swelling, or itching around the injection site. Mild allergic symptoms can occur, and there is a very rare risk of a more severe allergic reaction, which the clinic staff are trained to manage immediately. Joining is entirely your choice, and you can change your mind and leave the study at any time without it affecting your regular NHS medical care.

المواقع (1)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • —
    غير مؤكد
    إسبانيا

أسئلة شائعة

What is an allergy injection (immunotherapy)?

It is a treatment that delivers tiny amounts of the substance you are allergic to under the skin. Over time, it helps your immune system get used to the allergen so you react less.

Will I definitely receive the real allergy treatment?

No. You have an equal chance of receiving the active allergy injection or a dummy injection (placebo). A computer decides this at random.

Can I still take allergy relief medicines if I need them?

Yes. The trial team will supply you with approved rescue medicines (like antihistamine tablets and sprays) to take if your symptoms become uncomfortable.

Can I take part if I have asthma?

Yes, as long as your asthma is well-controlled and linked to your dust mite allergy. People with uncontrolled or severe asthma cannot take part.

Does taking part cost anything?

No. All study-related visits, injections, and rescue medications are provided free of charge, and travel expenses may be covered.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.